Novo Nordisk A S

XXEC, Inc. NVO
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/17/2026
Shares
830,388
Value ($000)
37,320
Weight
4.8%
2025 Q2 - 2026 Q2 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).